mellitus in Medical News

Industry And FDA Leaders To Discuss The Evolving Science Of Cardiovascular Safety (CV) And Diabetic Drug Development

... Safety and Development of Type 2 Diabetes mellitus Medications from September 23-24, 2009 in ... Safety and Development of Type 2 Diabetes mellitus Medications from September 23-24, 2009 in ... Therapies and targets for treatment of Diabetes mellitus - potential implications on CV safety Glycemic ...

Novo Nordisk Insulin Analogs Have Proven Safety Profiles

... adult and pediatric patient with type 1 diabetes mellitus or adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the ... for the treatment of patients with diabetes mellitus for the control of hyperglycemia. ...

What is the relationship between hepatocellular carcinoma and type 2 diabetes mellitus?

... cause of cancer-related deaths. Type 2 diabetes mellitus has been associated with HCC. However, the relationship between type 2 diabetes mellitus and the underlying liver cirrhosis, and the ... were calculated. The prevalence of diabetes mellitus was 31.2% in HCC, 23.3% in cirrhotic patients and ...

Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes

... (R) ) in Patients with Type 2 Diabetes mellitus Inadequately Controlled with Metformin ... Colesevelam HCl in Subjects with Type 2 Diabetes mellitus on Metformin Therapy This post-hoc analysis ... (Januvia(R)) in Patients with Type 2 Diabetes mellitus Inadequately Controlled with Metformin ...

Diabetes doubles liver cancer risk for patients with advanced hepatitis C

... cancer risk of patients who have both diabetes mellitus and advanced hepatitis C. They used data from ... likely to be diabetic. The prevalence of diabetes mellitus was 10.5 percent for patients with Ishak fibrosis ... hepatitis C and advanced cirrhosis, diabetes mellitus increases the risk of developing HCC, the authors ...

Benefit of glinides is not proven

... summary is now available. Therapy option for patients with diabetes mellitus type 2 Usually, treatment for diabetes mellitus type 2, formerly known as adult-onset diabetes, starts with non-drug ...

Novo Nordisk Warns Customers About Stolen Insulin

... for the treatment of adult and pediatric patients with type 1 diabetes mellitus or adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the control of hyperglycemia. ...

Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) Study

... for the treatment of adult and pediatric patients with type 1 diabetes mellitus or adult patients with type 2 diabetes mellitus who require basal (long-acting) insulin for the control of hyperglycemia. ...

Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists 'Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus'

... Control guideline recommendations in patients with type 2 diabetes mellitus and are intended to assist in the treatment of these patients, including ... control (measured as hemoglobin A1C) in adults with type 2 diabetes mellitus in combination with metformin, sulfonylureas, or insulin, either alone or ...

How Patients Can Meet the Criteria for Insulin Pump Therapy

... While many health plan insurers will pay for patients with type 1 diabetes mellitus to have an insulin pump, the criteria for approval is not always clear. ... who are willing and able to comply with prescribed type 1 diabetes mellitus self-care behavior that includes frequent monitoring of blood sugars, ...

Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019

... (IDF), of the 250 million people globally who suffer from Diabetes mellitus one out of six will develop a Diabetic Ulcer. To put that into ... a number of clinical conditions including complications from Diabetic mellitus such as Diabetic Neuropathy (DN) and diabetic ulcers (DU), auto-immune ...

Mayo Clinic researchers: Insulin-boosting medication does not impair ability to survive heart attack

... helped clarify a growing concern about the link between diabetes mellitus treatments and heart attack with the first large, population-based study ... Significance of the Mayo Clinic Study The prevalence of diabetes mellitus is growing rapidly, and physicians need evidence for their treatment ...

Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others

... Pancreatic cancer is the fourth leading cause of death from cancer for both men and women in the U.S. The association of type II diabetes mellitus and pancreatic cancer is complex. On one hand, type II diabetes can occur as a consequence of pancreatic cancer. On the other hand, there is ...

New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies

... if severe rash develops. Sulfa Allergy: PREZISTA should be used with caution in patients with known sulfonamide allergy. Diabetes mellitus / Hyperglycemia and Hemophilia: New-onset or exacerbations of preexisting diabetes mellitus, hyperglycemia, and increased bleeding in hemophiliacs ...

Researchers find possible environmental causes for Alzheimer's, diabetes

... link between increased levels of nitrates in our environment and food with increased deaths from diseases, including Alzheimer's, diabetes mellitus and Parkinson's. The study was published in the Journal of Alzheimer's Disease (Volume 17:3 July 2009). Led by Suzanne de la Monte, MD, MPH, of ...

Pre-Diabetes Costs Nation $25 Billion Annually in Extra Medical Care, New Data Show

... programs that have been shown to prevent or at least delay the onset of pre-diabetes." Gestational Diabetes Gestational diabetes mellitus (GDM) affects 4.5 percent of pregnancies that result in deliveries and is associated with significantly higher rates of medical complications for ...

TGen and USC researchers find genetic markers to help fight diabetes

... to the drug with the expected improvement in insulin sensitivity. TZDs are a class of insulin-sensitizing drugs used to treat type 2 diabetes mellitus (T2DM). TZDs are agonists for the nuclear receptor peroxisome proliferator-activated receptor-g (PPARG). Although the exact mechanism by which TZDs ...

InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting

... (TZD) therapy but with less hematocrit reduction and weight gain. The 4 week double blind placebo controlled study of INT131 in Type 2 Diabetes mellitus (T2DM) patients previously not on pharmacological therapy showed a dose dependent decrease in fasting plasma glucose (FPG) at 4 weeks, the primary ...

LSUHSC researchers first to document early signs for diabetes in kids as young as 7

... of the NIH-funded study which is investigating the importance of birth weight to diabetes. The increasing prevalence of type 2 diabetes mellitus in children parallels the pediatric obesity epidemic. According to the American Academy of Pediatrics, over the past two decades, the prevalence of ...

Arterial disease of the leg frequently overlooked in patients with heart disease

... coronary angiography and/or intervention and were either at least 70 years old, or between the ages of 50 and 69 and had a history of diabetes mellitus and/or tobacco use. Researchers determined if patients had PAD by calculating the Ankle-Brachial Index, the ratio of the blood pressure in the lower ...

ADA releases position paper on obesity, reproduction and pregnancy outcomes

... induced by hormonal changes in pregnancy create a metabolic milieu that enhances the risk for metabolic disorders such as gestational diabetes mellitus and preeclampsia," according to the position paper. Infants born to obese mothers have "a higher prevalence of congenital anomalies than do ...

Four legendary LA BioMed physician-researchers honored

... in all aspects of pediatric endocrinology and reproductive endocrinology in health and disease with emphasis on hypoglycemic syndromes and diabetes mellitus with recent focus on neonatal diabetes and the Mody Syndromes. He has had continuous funding from the National Institutes of Health since 1972, also ...

The Traveling Nut: Researchers From Around the World Explore the Impact of Almonds on the Body

... including almonds, may have for our diets and health. Study at a Glance: Subjects: 120 Non-insulin dependent subjects with diabetes mellitus treated with oral hypoglycemic agents. Methods: In the three-month parallel study subjects were randomized to receive one of the three ...

Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation

... two late-stage products. We partnered with the Phenomix Corporation to develop and commercialize dutogliptin, for the treatment of Type 2 diabetes mellitus and with Pierre Fabre Medicament to develop and commercialize levomilnacipran for the treatment of depression. In fiscal 2010, we will continue ...

Pancreatic Islets in Forefront of Diabetes Research

... exception of one report in a type 2 diabetes cohort, islet transplantation has been used exclusively for a subset of individuals with type 1 diabetes mellitus and was shown, at least temporarily, to improve glucose control and, in a few cases, to lead to insulin independence." Cell replacement therapy ...

Low Blood Sugar Events Increase Dementia Risk in Elderly Patients With Type 2 Diabetes, Kaiser Permanente Study Finds

... be controlled in patients with type 2 diabetes, particularly in elderly patients, say the researchers. The study appears in the current diabetes mellitus themed issue of JAMA. While several studies have shown low blood sugar to affect cognitive function in children with type 1 diabetes, this is ...

Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven

... by means of which key therapy options for people with diabetes are to be assessed. The reports on rapid-acting insulin analogues in diabetes mellitus type 1 and 2 have already been completed. Only one study lasting longer than 12 months was available For the assessment of the LAIAs, IQWiG ...

New Survey Highlights the Significant Impact of the Economic Downturn on Europe's Sleep

... and increased body mass index. PLoS Med 2004; 1(3): e62 8. Gottlieb DJ, Punjabi NM, Newman AB et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005; 165(8): 863-7 9. Gumustekin K, Seven B, Karabulut N et al. Effects of sleep deprivation, ...

Dendritic cells ensure immune tolerance

... self. If this distinction fails, then the body's own structures will be attacked, the result of which could be an autoimmune disease such as diabetes mellitus type 1 or multiple sclerosis. The only way to protect against these afflictions is to destroy all immune factors that turn against the body's own ...

New published study demonstrates over-the-counter device lowers blood pressure in diabetic patients

... the patients reported feeling more relaxed after the device-guided breathing." Hypertension is a common co-morbidity in patients with diabetes mellitus and is an important factor in the increased risk of coronary heart disease and stroke in diabetics. Lowering blood pressure in the diabetic ...

Takeda Receives New Information on Alogliptin (SYR-322) NDA

... Drug User Fee Act (PDUFA) date - June 26, 2009 - remains unchanged. In December, 2008 the FDA issued "Guidance for Industry: Diabetes mellitus -- Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes". In October 2008, Takeda received notification from ...

Study shows potential for resolving type 2 diabetes with bariatric surgery

... New York, March 3, 2009 As the incidence of obesity-induced type 2 diabetes mellitus continues to increase worldwide, medical research indicates that surgery to reduce obesity can completely eliminate all manifestations of diabetes. ...

Pennsylvanians May Donate Part of Tax Refund to Support Juvenile Diabetes Research

... people effectively manage their diabetes and enjoy active, healthy lives." Type 1 diabetes, previously known as insulin-dependent diabetes mellitus (IDDM) or juvenile-onset diabetes, results when the immune system destroys the insulin-producing cells of the pancreas that regulates blood glucose. ...

New analysis shows liver cancer incidence has tripled since 1970s, but survival rates improving

... be vital to preventing these rates from rising further." Dr. Altekruse noted that heavy alcohol consumption, fatty liver disease, obesity, diabetes mellitus and iron storage diseases may also contribute to the increasing incidence of liver cancer. The study found that between 1975 and 2005, liver ...

LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth

... beta cells the only cells in the body that secrete insulin. Beta cells are located in islet cell clusters throughout the pancreas. Diabetes mellitus type 1 results from the destruction or dysfunction of islets and their beta cells. Type 2 diabetes results from the body's inability to use insulin ...

Preeclampsia in Pregnancy Boosts Future Health Risks

... of the baby. But while delivery may 'cure' preeclampsia in the moment, these mothers are at high risk of chronic hypertension, type 2 diabetes mellitus and blood clots for the rest of their lives," senior author Dr. Michael J. Paidas, director of the Program for Thrombosis and Hemostasis in Women's ...

Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk

... Heart Association. Cardiovascular disease claims about as many lives each year as cancer, chronic lower respiratory diseases, accidents and diabetes mellitus combined. The National Heart, Lung, and Blood Institute funded portions of the study. Co-authors are: Kiang Liu, Ph.D.; Aaron R. Folsom, ....

Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals

... California. Other than crofelemer, Napo's pipeline has an early clinical stage drug candidate, NP-500, for the treatment of Type II diabetes mellitus and metabolic syndrome and novel and proprietary anti-cancer agents in pre-clinical development. Napo also has a plant library of approximately ...

Study finds selenium, vitamin E do not prevent prostate cancer

... two statistically non-significant findings of concern: slightly increased risks of prostate cancer in the vitamin E group and type two diabetes mellitus in the selenium group. Both trends may be due to chance and were not observed in the group taking selenium and vitamin E together. An independent ...

Diabetic Eye Disease Rates Soaring

... $500 million was spent on direct medical costs for diabetic retinopathy, according to background information in the study. "People with diabetes mellitus also have a higher prevalence of other eye diseases, such as cataracts and glaucoma, than the general population," the researchers wrote. "Vision ...